Janux Therapeutics, Inc. (NASDAQ:JANX) Given Average Rating of “Buy” by Analysts
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has earned an average recommendation of “Buy” from the eleven brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has earned an average recommendation of “Buy” from the eleven brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the […]
